Temasek leads $50m Series B in digital health firm PEAR Therapeutics, EDBI joins round

Temasek leads $50m Series B in digital health firm PEAR Therapeutics, EDBI joins round

A Temasek Holdings Pte employee walks past the company's signage in their office in Singapore. Photographer: Munshi Ahmed/Bloomberg

Singapore’s state-run investment firm Temasek Holdings Private Ltd led a $50 million Series B investment in US-based digital health firm PEAR Therapeutics.

Singapore-based EDBI also joined the round, along with new and existing investors including 5AMVentures, Arboretum Ventures, JAZZ Venture Partners, Novartis and the Bridge Builder’s Collaborative, according to a company statement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter